BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10101373)

  • 1. Harm reduction drug policies and practice: international developments and domestic initiatives. Overview of a symposium. March 22, 1995.
    Drucker E; Hantman JA
    Bull N Y Acad Med; 1995; 72(2):335-8. PubMed ID: 10101373
    [No Abstract]   [Full Text] [Related]  

  • 2. The Harm Reduction Coalition.
    Clear A; Springer E; Lanier C
    Newsline People AIDS Coalit N Y; 1998 Jun; ():27-34. PubMed ID: 11367469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New drug policies: the Geneva example].
    Mino A
    Psychiatr Enfant; 1994; 37(2):577-99. PubMed ID: 7878141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm reduction in Bern: from outreach to heroin maintenance.
    Haemmig RB
    Bull N Y Acad Med; 1995; 72(2):371-9. PubMed ID: 10101377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reduction of drug abuse ... a true public health paradigm].
    Provost F
    Perspect Infirm; 2005; 2(3):44-5. PubMed ID: 15686213
    [No Abstract]   [Full Text] [Related]  

  • 6. Harm Reduction: Front Line Public Health.
    Stancliff S; Phillips BW; Maghsoudi N; Joseph H
    J Addict Dis; 2015; 34(2-3):206-19. PubMed ID: 26080038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harm reduction is a good label for a criterion all drug programs should meet.
    Maccoun RJ
    Addiction; 2009 Mar; 104(3):341-2; discussion 345-6. PubMed ID: 19207338
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Youth without drugs". No!].
    Krankenpfl Soins Infirm; 1997 Aug; 90(8):36-7. PubMed ID: 9370610
    [No Abstract]   [Full Text] [Related]  

  • 9. The relationship between take-away methadone policies and methadone diversion.
    Ritter A; Di Natale R
    Drug Alcohol Rev; 2005 Jul; 24(4):347-52. PubMed ID: 16234130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The children of mama coca: coca, cocaine and the fate of harm reduction in South America.
    Bastos FI; Caiaffa W; Rossi D; Vila M; Malta M
    Int J Drug Policy; 2007 Mar; 18(2):99-106. PubMed ID: 17689352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supply reduction's hidden casualties: a view from the trenches.
    Strathdee SA; Patterson TL
    Addiction; 2009 Mar; 104(3):340-1; discussion 345-6. PubMed ID: 19207337
    [No Abstract]   [Full Text] [Related]  

  • 12. [Withdrawal programmes for narcotics addicts in the USA].
    Neudek K
    Munch Med Wochenschr; 1970 May; 112(22):1054-6. PubMed ID: 4987316
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.
    Drucker E; Lurie P; Wodak A; Alcabes P
    AIDS; 1998; 12 Suppl A():S217-30. PubMed ID: 9633006
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating national harm reduction programs.
    Des Jarlais DC
    Addiction; 2005 Nov; 100(11):1575-6. PubMed ID: 16277620
    [No Abstract]   [Full Text] [Related]  

  • 15. 'Social evils' and harm reduction: the evolving policy environment for human immunodeficiency virus prevention among injection drug users in China and Vietnam.
    Hammett TM; Wu Z; Duc TT; Stephens D; Sullivan S; Liu W; Chen Y; Ngu D; Des Jarlais DC
    Addiction; 2008 Jan; 103(1):137-45. PubMed ID: 18028519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harm reduction is now the mainstream global drug policy.
    Wodak A
    Addiction; 2009 Mar; 104(3):343-5; discussion 345-6. PubMed ID: 19207340
    [No Abstract]   [Full Text] [Related]  

  • 17. Harm reduction and the global drug control regime: contemporary problems and future prospects.
    Bewley-Taylor DR
    Drug Alcohol Rev; 2004 Dec; 23(4):483-9. PubMed ID: 15763753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A decade of caring for drug users.
    Byrne A
    Br J Gen Pract; 1999 Feb; 49(439):146. PubMed ID: 10326275
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapid scale up of harm reduction in China.
    Sullivan SG; Wu Z
    Int J Drug Policy; 2007 Mar; 18(2):118-28. PubMed ID: 17689354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.